PIPELINE
RevolKaは、aiProtein®固有の適応範囲の広さを活かし、様々な疾患に対する治療薬開発及び各種領域の新規タンパク質の開発を行っています。
また、抗体の高機能化に関する受託サービスを行っております。
本受託サービスは、富士フイルム和光純薬株式会社を通じて提供しておりますので、詳しくは、富士フイルム和光純薬株式会社のホームページをご覧ください。
2025年1月31日時点 | |||||
Project | Modality | Area | Development Stage | Status | Partner |
---|---|---|---|---|---|
RK001 | Antibody | Therapeutics (Immunooncotherapy) |
Technology development |
Completed | ![]() |
RK002 | Antibody | Therapeutics (Oncology) |
Technology development |
Completed | ![]() |
RK003 | Protein | Therapeutics (Rare Disease) |
Undisclosed | Completed | ![]() |
RK004 | Protein | Undisclosed | Undisclosed | Completed | ![]() |
RK006 |
Protein |
Undisclosed |
Undisclosed |
Working | Undisclosed |
RK007 | Protein | Undisclosed | Undisclosed | Completed | ![]() |
RK008 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
RK009 | Protein | Vaccines (Infectious diseases) |
Research collaboration |
Working | ![]() |
RK010 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
RK011 | Protein | Undisclosed | Undisclosed | Completed | ![]() |
RK012 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
RK013 | Protein | Undisclosed | Undisclosed | New | Undisclosed |
RK014 | Protein | Undisclosed | Undisclosed | New | Undisclosed |
RK015 | Protein | Undisclosed | Undisclosed | New | ![]() |
RK016 | Protein | Undisclosed | Undisclosed | New | ![]() |